Dysbiosis associated with PCOS results in reduced production of IL-22 [87] and exogenous administration of this cytokine was able to reverse many of the clinical phenotypes typical of PCOS such as insulin resistance, abnormal ovarian morphology, and defects in estrous cycle in animal models [88]. The gene discussed is IL22; the disease is polycystic ovary syndrome.